Camptothecin causes cell cycle perturbations within T-lymphoblastoid cells followed by dose dependent induction of apoptosis

被引:49
作者
Johnson, N [1 ]
Ng, TTC [1 ]
Parkin, JM [1 ]
机构
[1] ST BARTHOLOMEWS & ROYAL LONDON COLL MED & DENT, DEPT IMMUNOL, LONDON EC1A 7BE, ENGLAND
基金
英国医学研究理事会;
关键词
camptothecin; apoptosis; Jurkat T-cell; cell cycle;
D O I
10.1016/S0145-2126(97)00077-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have investigated the effect of the anticancer compound, camptothecin on Jurkat T-cells, a lymphoblastoid leukemic cell-line. Exposure to low concentrations led to rapid cessation of DNA (more than 95%) and RNA (more than 75%) synthesis. Perturbations to the cell cycle were observed following exposure which caused a significant accumulation of cells within G1 (P=0.03) with a concomitant decrease in G2/M (P=0.025), Concentrations below 0.1 mu M could inhibit DNA synthesis but not induce apoptosis. Induction of apoptosis was dose dependent and could be detected as early as 3 h post exposure, The apoptotic population appeared to be derived from G1 and S-phase cells but not G2/M, coinciding with the cell cycle compartments in which DNA and RNA polymerases function. However, direct inhibition of DNA polymerase alone was not shown to be associated the induction of apoptosis or with a decrease in susceptibility to camptothecin-induced cell death, The effects of camptothecin on Jurkat T-cells and the potential mechanisms involved are discussed in the context of observations made in other transformed cell lines, (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:961 / 972
页数:12
相关论文
共 37 条
[21]   P53 IS REQUIRED FOR RADIATION-INDUCED APOPTOSIS IN MOUSE THYMOCYTES [J].
LOWE, SW ;
SCHMITT, EM ;
SMITH, SW ;
OSBORNE, BA ;
JACKS, T .
NATURE, 1993, 362 (6423) :847-849
[22]  
LUI LF, 1989, ANNU REV BIOCHEM, V58, P351
[23]   FAS AND FASL IN THE HOMEOSTATIC REGULATION OF IMMUNE-RESPONSES [J].
LYNCH, DH ;
RAMSDELL, F ;
ALDERSON, MR .
IMMUNOLOGY TODAY, 1995, 16 (12) :569-574
[24]   Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases [J].
Meikrantz, W ;
Schlegel, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (17) :10205-10209
[25]   A RAPID AND SIMPLE METHOD FOR MEASURING THYMOCYTE APOPTOSIS BY PROPIDIUM IODIDE STAINING AND FLOW-CYTOMETRY [J].
NICOLETTI, I ;
MIGLIORATI, G ;
PAGLIACCI, MC ;
GRIGNANI, F ;
RICCARDI, C .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 139 (02) :271-279
[26]  
OCONNOR PM, 1993, J BIOL CHEM, V268, P8298
[27]   DISTINCT PATTERNS OF CELL-CYCLE DISTURBANCE ELICITED BY COMPOUNDS INTERFERING WITH DNA TOPOISOMERASE-I AND TOPOISOMERASE-II ACTIVITY [J].
POOT, M ;
HILLER, KH ;
HEIMPEL, S ;
HOEHN, H .
EXPERIMENTAL CELL RESEARCH, 1995, 218 (01) :326-330
[28]  
PORFIRI E, 1988, EXP HEMATOL, V16, P641
[29]   Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I [J].
Rossi, F ;
Labourier, E ;
Forne, T ;
Divita, G ;
Derancourt, J ;
Riou, JF ;
Antoine, E ;
Cathala, G ;
Brunel, C ;
Tazi, J .
NATURE, 1996, 381 (6577) :80-82
[30]   Bioavailability and pharmacokinetics of oral topotecan: A new topoisomerase I inhibitor [J].
Schellens, JHM ;
Creemers, GJ ;
Beijnen, JH ;
Rosing, H ;
deBoerDennert, M ;
McDonald, M ;
Davies, E ;
Verweij, J .
BRITISH JOURNAL OF CANCER, 1996, 73 (10) :1268-1271